Education
About Us
Working with TipRanks
Follow Us
Wellnex Life Ltd (AU:WNX)
ASX:WNX
WNX Stock Chart & Stats
AU$0.09
AU$0.01(1.47%)
At close: 4:00 PM EST
AU$0.09
AU$0.01(1.47%)
Day’s Range― - ―
52-Week RangeAU$0.09 - AU$0.66
Previous CloseN/A
Volume2.27K
Average Volume (3M)51.95K
Market Cap
AU$7.70M
Enterprise ValueAU$12.65M
Total Cash (Recent Filing)AU$497.00K
Total Debt (Recent Filing)AU$5.45M
Price to Earnings (P/E)―
Beta1.67
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding69,955,475
10 Day Avg. Volume31,968
30 Day Avg. Volume51,946
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.69
Price to Sales (P/S)0.33
P/FCF Ratio-11.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Own Brands & Pharmacy DistributionWellnex’s core model—owning brands and distributing OTC consumer-health products through pharmacy and retail channels—creates durable recurring revenue pathways. Control of branding and channel relationships supports repeat purchases, shelf presence and leverageable marketing spend over months.
Manageable LeverageA debt-to-equity around 0.48 indicates moderate leverage that preserves financial flexibility. With manageable obligations the company can fund working capital and product rollouts without excessive interest burden, supporting operational continuity and strategic investment over the medium term.
Recent Revenue ExpansionA sizable reported revenue increase suggests accelerating product adoption or successful distribution execution. Sustained top-line growth supports scale benefits, stronger negotiating power with retailers, and the potential to dilute fixed costs, improving long-term margin recovery if maintained.
Bears Say
Negative ProfitabilityPersistent negative EBIT and net margins show the company cannot yet convert gross profit into operating profitability. Over months this erodes retained earnings, limits reinvestment capacity and risks requiring external capital unless structural margin improvements or cost reduction programs are executed.
Weak Cash GenerationNegative operating and free cash flows indicate the business is consuming cash to run core operations and fund growth. This durable weakness constrains the ability to self-fund inventory, marketing and R&D, raising reliance on external financing and increasing vulnerability to funding cost or availability shifts.
Negative Return On EquityA negative ROE signals shareholder capital is not producing returns and reflects ongoing losses. Over time this undermines investor confidence and could raise the cost of new equity or debt, limiting strategic options and making it harder to fund growth or respond to competitive pressures.
Wellnex Life Ltd News
WNX FAQ
What was Wellnex Life Ltd’s price range in the past 12 months?
Wellnex Life Ltd lowest share price was AU$0.09 and its highest was AU$0.66 in the past 12 months.
What is Wellnex Life Ltd’s market cap?
Wellnex Life Ltd’s market cap is AU$7.70M.
When is Wellnex Life Ltd’s upcoming earnings report date?
Wellnex Life Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 9 days.
How were Wellnex Life Ltd’s earnings last quarter?
Wellnex Life Ltd released its earnings results on Aug 29, 2025. The company reported -AU$0.119 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.119.
Is Wellnex Life Ltd overvalued?
According to Wall Street analysts Wellnex Life Ltd’s price is currently Overvalued.
Does Wellnex Life Ltd pay dividends?
Wellnex Life Ltd does not currently pay dividends.
What is Wellnex Life Ltd’s EPS estimate?
Wellnex Life Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellnex Life Ltd have?
Wellnex Life Ltd has 69,955,475 shares outstanding.
What happened to Wellnex Life Ltd’s price movement after its last earnings report?
Wellnex Life Ltd reported an EPS of -AU$0.119 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.128%.
Which hedge fund is a major shareholder of Wellnex Life Ltd?
Currently, no hedge funds are holding shares in AU:WNX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Wellnex Life Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.14%
12-Months-Change
Fundamentals
Return on Equity
-184.71%
Trailing 12-Months
Asset Growth
-18.52%
Trailing 12-Months
Company Description
Wellnex Life Ltd
Wellnex Life Limited develops health and wellness solutions in Australia. The company provides organic baby skincare products under the Little Innoscents; nutritional support products under the Performance Inspired; iron gummies under The Iron Company; organic milk under the Uganic; natural energy products under the Wakey Wakey; smooth textured capsules under the Liquigesic; and garlic products under the SupaGarlic brands. It also offers bin cleanser solutions under the Bin Buddy; medical products under the Bird Healthcare; gel plasters for treating blisters, corns, cracked heels, and cold sores under the Compeed; oral emergency contraception pills under the EllaOne; skincare solutions under the Koéna; canned meats under the Plumrose; snacks under the Simply7; skincare products under the edited; natural herbal skincare products under the naked klay; and natural essential oil blends under the Planet Remedy brands. In addition, the company provides contract manufacturing services. Wellnex Life Limited has a collaboration with Onelife Botanicals for the manufacture, distribution, and sales of cannabis and hemp-based products. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Melbourne, Australia.
Technical Analysis
EVE Health Group Limited
―
Nuchev Pty Ltd
―
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---